YAP1 and neoplasm: Treating tumor cells with YAP/TAZ inhibitors, such as verteporfin, significantly reversed the malignant biological behavior of the tumor cells [8–11], indicating the therapeutic value of targeting YAP/TAZ signaling in cancer.